10 kHz spinal cord stimulation: a retrospective analysis of real-world data from a community-based, interdisciplinary pain facility
Open Access
- 1 November 2018
- journal article
- research article
- Published by Taylor & Francis in Journal of Pain Research
- Vol. ume 11, 2929-2941
Abstract
Objective: To evaluate clinical outcomes and health care utilization at 12 months post spinal cord stimulator (SCS) implantation compared with baseline and a matched sample of patients receiving conventional medical management (CMM) for the treatment of low back and lower extremity pain. Patients: A retrospective study of patients with at least 24 months of active treatment at an interdisciplinary community pain center between December 1, 2014 and December 31, 2017. Thirty-two patients receiving implantation of a high-frequency (10 kHz) SCS and 64 patients receiving CMM were identified through propensity matching at a ratio of 2:1. Methods: Data were extracted from medical records, including pain severity, prescribed opioid dose in morphine milligram equivalents, patient perception of disability, and volume of interventional pain procedures and total office visits to the pain center. Results: Reductions in opioid dose were significantly greater for the SCS group than the CMM group. The 26.2 mg morphine equivalent dose reduction represents a 28% reduction from baseline, with 71.4% of those prescribed opioids in the SCS group reducing their dose at 12 months post-implant. Among those with SCS, there were significant within-group reductions in numerical pain score for low back and lower extremity pain, reducing by 46.2% and 50.9% from baseline, respectively. Change in functional pain score was not significant for either SCS group or CMM. Both groups had significant within-group reduction in disability. Reduction of interventional procedure volume was significant for both groups with a greater reduction observed in the SCS group. Office visit volume reduction was significant for the CMM group, but this was not a significant difference from the SCS group. Conclusions: Results support the efficacy of 10 kHz SCS for analgesia, reduction of opioid utilization, reduction of interventional pain procedures, and patient perception of disability.Keywords
This publication has 46 references indexed in Scilit:
- Psychometric properties of selected tests in patients with lumbar spinal stenosisThe Spine Journal, 2012
- Optimal caliper widths for propensity‐score matching when estimating differences in means and differences in proportions in observational studiesPharmaceutical Statistics, 2011
- Reliability, Construct Validity, and Responsiveness of the Neck Disability Index, Patient-Specific Functional Scale, and Numeric Pain Rating Scale in Patients with Cervical RadiculopathyAmerican Journal of Physical Medicine & Rehabilitation, 2010
- Developing the World Health Organization Disability Assessment Schedule 2.0Bulletin of the World Health Organization, 2010
- A Strategy for Health Care Reform — Toward a Value-Based SystemNew England Journal of Medicine, 2009
- Validation and Standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the General PopulationMedical Care, 2008
- Accuracy of the Pain Numeric Rating Scale as a Screening Test in Primary CareJournal of General Internal Medicine, 2007
- A Brief Measure for Assessing Generalized Anxiety DisorderArchives of internal medicine (1960), 2006
- The PHQ-9Journal of General Internal Medicine, 2001
- A Study of the Natural History of Back PainSpine, 1983